Baguinda, Baby Boy .

HRN: 25-33-08  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2024
AMPICILLIN 250MG (VIAL)
06/21/2024
06/28/2024
IV
190mg
Q 8 Hours
Neonatal Sepsis
Waiting Final Action 
06/21/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/21/2024
06/28/2024
IV
23 Mg
Q 24
Neonatal Sepsis
Waiting Final Action 
06/22/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
06/22/2024
06/29/2024
IV
38mg As LD; 22mg As MD
Q48
Sepsis
Waiting Final Action 
06/23/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/23/2024
06/30/2024
IVT
29 Mg As LD Then 14 Mg As Maintenance Dose
Q8
Intra-Abdominal Infection
Waiting Final Action 
06/23/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/23/2024
06/30/2024
IV DRIP
285mg
Q12
Neonatal Sepsis
Waiting Final Action 
06/23/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
06/23/2024
06/30/2024
IVT
10mg
Q24
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: